Nuclear Medicine Radioisotopes Market Size, Share, Growth, and Industry Analysis, By Types (Rubidium-82 (Rb-82), Actinium-225 (Ac-225), Radium-223 (Ra-223) & Alpharadin, Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Iodine-131 (I-131), Lutetium-177 (Lu-177), Others), By Applications (Oncology, Cardiology, Lymphoma, Thyroid, Neurology, Others), Regional Insights and Forecast to 2033

Detailed TOC of Global Nuclear Medicine Radioisotopes Industry Research Report 2025, Competitive Landscape, Market Size, Regional Status and Prospect

1 Nuclear Medicine Radioisotopes Market Overview
1.1 Product Overview and Scope of Nuclear Medicine Radioisotopes Market
1.2 Nuclear Medicine Radioisotopes Market Segment by Type
1.2.1 Global Nuclear Medicine Radioisotopes Market Sales Volume and CAGR (%) Comparison by Type (2018-2033)
1.3 Global Nuclear Medicine Radioisotopes Market Segment by Application
1.3.1 Nuclear Medicine Radioisotopes Market Consumption (Sales Volume) Comparison by Application (2018-2033)
1.4 Global Nuclear Medicine Radioisotopes Market, Region Wise (2018-2033)
1.4.1 Global Nuclear Medicine Radioisotopes Market Size (Revenue) and CAGR (%) Comparison by Region (2018-2033)
1.4.2 United States Nuclear Medicine Radioisotopes Market Status and Prospect (2018-2033)
1.4.3 Europe Nuclear Medicine Radioisotopes Market Status and Prospect (2018-2033)
1.4.4 China Nuclear Medicine Radioisotopes Market Status and Prospect (2018-2033)
1.4.5 Japan Nuclear Medicine Radioisotopes Market Status and Prospect (2018-2033)
1.4.6 India Nuclear Medicine Radioisotopes Market Status and Prospect (2018-2033)
1.4.7 Southeast Asia Nuclear Medicine Radioisotopes Market Status and Prospect (2018-2033)
1.4.8 Latin America Nuclear Medicine Radioisotopes Market Status and Prospect (2018-2033)
1.4.9 Middle East and Africa Nuclear Medicine Radioisotopes Market Status and Prospect (2018-2033)
1.5 Global Market Size of Nuclear Medicine Radioisotopes (2018-2033)
1.5.1 Global Nuclear Medicine Radioisotopes Market Revenue Status and Outlook (2018-2033)
1.5.2 Global Nuclear Medicine Radioisotopes Market Sales Volume Status and Outlook (2018-2033)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Nuclear Medicine Radioisotopes Market

2 Industry Outlook
2.1 Nuclear Medicine Radioisotopes Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Nuclear Medicine Radioisotopes Market Drivers Analysis
2.4 Nuclear Medicine Radioisotopes Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Nuclear Medicine Radioisotopes Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Nuclear Medicine Radioisotopes Industry Development

3 Global Nuclear Medicine Radioisotopes Market Landscape by Player
3.1 Global Nuclear Medicine Radioisotopes Sales Volume and Share by Player (2018-2025)
3.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Player (2018-2025)
3.3 Global Nuclear Medicine Radioisotopes Average Price by Player (2018-2025)
3.4 Global Nuclear Medicine Radioisotopes Gross Margin by Player (2018-2025)
3.5 Nuclear Medicine Radioisotopes Market Competitive Situation and Trends
3.5.1 Nuclear Medicine Radioisotopes Market Concentration Rate
3.5.2 Nuclear Medicine Radioisotopes Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion

4 Global Nuclear Medicine Radioisotopes Sales Volume and Revenue Region Wise (2018-2025)
4.1 Global Nuclear Medicine Radioisotopes Sales Volume and Market Share, Region Wise (2018-2025)
4.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share, Region Wise (2018-2025)
4.3 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.4 United States Nuclear Medicine Radioisotopes Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.4.1 United States Nuclear Medicine Radioisotopes Market Under COVID-19
4.5 Europe Nuclear Medicine Radioisotopes Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.5.1 Europe Nuclear Medicine Radioisotopes Market Under COVID-19
4.6 China Nuclear Medicine Radioisotopes Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.6.1 China Nuclear Medicine Radioisotopes Market Under COVID-19
4.7 Japan Nuclear Medicine Radioisotopes Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.7.1 Japan Nuclear Medicine Radioisotopes Market Under COVID-19
4.8 India Nuclear Medicine Radioisotopes Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.8.1 India Nuclear Medicine Radioisotopes Market Under COVID-19
4.9 Southeast Asia Nuclear Medicine Radioisotopes Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.9.1 Southeast Asia Nuclear Medicine Radioisotopes Market Under COVID-19
4.10 Latin America Nuclear Medicine Radioisotopes Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.10.1 Latin America Nuclear Medicine Radioisotopes Market Under COVID-19
4.11 Middle East and Africa Nuclear Medicine Radioisotopes Sales Volume, Revenue, Price and Gross Margin (2018-2025)
4.11.1 Middle East and Africa Nuclear Medicine Radioisotopes Market Under COVID-19

5 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue, Price Trend by Type
5.1 Global Nuclear Medicine Radioisotopes Sales Volume and Market Share by Type (2018-2025)
5.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Type (2018-2025)
5.3 Global Nuclear Medicine Radioisotopes Price by Type (2018-2025)
5.4 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue and Growth Rate by Type (2018-2025)
5.4.1 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue and Growth Rate of Rubidium-82 (Rb-82) (2018-2025)
5.4.2 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue and Growth Rate of Actinium-225 (Ac-225) (2018-2025)
5.4.3 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue and Growth Rate of Radium-223 (Ra-223) & Alpharadin (2018-2025)
5.4.4 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue and Growth Rate of Technetium-99m (Tc-99m) (2018-2025)
5.4.5 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue and Growth Rate of Thallium-201 (Tl-201) (2018-2025)
5.4.6 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue and Growth Rate of Iodine (I-123) (2018-2025)
5.4.7 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue and Growth Rate of Fluorine-18 (2018-2025)
5.4.8 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue and Growth Rate of Iodine-131 (I-131) (2018-2025)
5.4.9 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue and Growth Rate of Lutetium-177 (Lu-177) (2018-2025)
5.4.10 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue and Growth Rate of Others (2018-2025)

6 Global Nuclear Medicine Radioisotopes Market Analysis by Application
6.1 Global Nuclear Medicine Radioisotopes Consumption and Market Share by Application (2018-2025)
6.2 Global Nuclear Medicine Radioisotopes Consumption Revenue and Market Share by Application (2018-2025)
6.3 Global Nuclear Medicine Radioisotopes Consumption and Growth Rate by Application (2018-2025)
6.3.1 Global Nuclear Medicine Radioisotopes Consumption and Growth Rate of Oncology (2018-2025)
6.3.2 Global Nuclear Medicine Radioisotopes Consumption and Growth Rate of Cardiology (2018-2025)
6.3.3 Global Nuclear Medicine Radioisotopes Consumption and Growth Rate of Lymphoma (2018-2025)
6.3.4 Global Nuclear Medicine Radioisotopes Consumption and Growth Rate of Thyroid (2018-2025)
6.3.5 Global Nuclear Medicine Radioisotopes Consumption and Growth Rate of Neurology (2018-2025)
6.3.6 Global Nuclear Medicine Radioisotopes Consumption and Growth Rate of Others (2018-2025)

7 Global Nuclear Medicine Radioisotopes Market Forecast (2025-2033)
7.1 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue Forecast (2025-2033)
7.1.1 Global Nuclear Medicine Radioisotopes Sales Volume and Growth Rate Forecast (2025-2033)
7.1.2 Global Nuclear Medicine Radioisotopes Revenue and Growth Rate Forecast (2025-2033)
7.1.3 Global Nuclear Medicine Radioisotopes Price and Trend Forecast (2025-2033)
7.2 Global Nuclear Medicine Radioisotopes Sales Volume and Revenue Forecast, Region Wise (2025-2033)
7.2.1 United States Nuclear Medicine Radioisotopes Sales Volume and Revenue Forecast (2025-2033)
7.2.2 Europe Nuclear Medicine Radioisotopes Sales Volume and Revenue Forecast (2025-2033)
7.2.3 China Nuclear Medicine Radioisotopes Sales Volume and Revenue Forecast (2025-2033)
7.2.4 Japan Nuclear Medicine Radioisotopes Sales Volume and Revenue Forecast (2025-2033)
7.2.5 India Nuclear Medicine Radioisotopes Sales Volume and Revenue Forecast (2025-2033)
7.2.6 Southeast Asia Nuclear Medicine Radioisotopes Sales Volume and Revenue Forecast (2025-2033)
7.2.7 Latin America Nuclear Medicine Radioisotopes Sales Volume and Revenue Forecast (2025-2033)
7.2.8 Middle East and Africa Nuclear Medicine Radioisotopes Sales Volume and Revenue Forecast (2025-2033)
7.3 Global Nuclear Medicine Radioisotopes Sales Volume, Revenue and Price Forecast by Type (2025-2033)
7.3.1 Global Nuclear Medicine Radioisotopes Revenue and Growth Rate of Rubidium-82 (Rb-82) (2025-2033)
7.3.2 Global Nuclear Medicine Radioisotopes Revenue and Growth Rate of Actinium-225 (Ac-225) (2025-2033)
7.3.3 Global Nuclear Medicine Radioisotopes Revenue and Growth Rate of Radium-223 (Ra-223) & Alpharadin (2025-2033)
7.3.4 Global Nuclear Medicine Radioisotopes Revenue and Growth Rate of Technetium-99m (Tc-99m) (2025-2033)
7.3.5 Global Nuclear Medicine Radioisotopes Revenue and Growth Rate of Thallium-201 (Tl-201) (2025-2033)
7.3.6 Global Nuclear Medicine Radioisotopes Revenue and Growth Rate of Iodine (I-123) (2025-2033)
7.3.7 Global Nuclear Medicine Radioisotopes Revenue and Growth Rate of Fluorine-18 (2025-2033)
7.3.8 Global Nuclear Medicine Radioisotopes Revenue and Growth Rate of Iodine-131 (I-131) (2025-2033)
7.3.9 Global Nuclear Medicine Radioisotopes Revenue and Growth Rate of Lutetium-177 (Lu-177) (2025-2033)
7.3.10 Global Nuclear Medicine Radioisotopes Revenue and Growth Rate of Others (2025-2033)
7.4 Global Nuclear Medicine Radioisotopes Consumption Forecast by Application (2025-2033)
7.4.1 Global Nuclear Medicine Radioisotopes Consumption Value and Growth Rate of Oncology(2025-2033)
7.4.2 Global Nuclear Medicine Radioisotopes Consumption Value and Growth Rate of Cardiology(2025-2033)
7.4.3 Global Nuclear Medicine Radioisotopes Consumption Value and Growth Rate of Lymphoma(2025-2033)
7.4.4 Global Nuclear Medicine Radioisotopes Consumption Value and Growth Rate of Thyroid(2025-2033)
7.4.5 Global Nuclear Medicine Radioisotopes Consumption Value and Growth Rate of Neurology(2025-2033)
7.4.6 Global Nuclear Medicine Radioisotopes Consumption Value and Growth Rate of Others(2025-2033)
7.5 Nuclear Medicine Radioisotopes Market Forecast Under COVID-19

8 Nuclear Medicine Radioisotopes Market Upstream and Downstream Analysis
8.1 Nuclear Medicine Radioisotopes Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Nuclear Medicine Radioisotopes Analysis
8.6 Major Downstream Buyers of Nuclear Medicine Radioisotopes Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Nuclear Medicine Radioisotopes Industry

9 Players Profiles
9.1 Segami Corporation
9.1.1 Segami Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.1.3 Segami Corporation Market Performance (2018-2025)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Positron Corporation
9.2.1 Positron Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.2.3 Positron Corporation Market Performance (2018-2025)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 NTP Radioisotopes SOC Ltd
9.3.1 NTP Radioisotopes SOC Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.3.3 NTP Radioisotopes SOC Ltd Market Performance (2018-2025)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Cardiarc Ltd
9.4.1 Cardiarc Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.4.3 Cardiarc Ltd Market Performance (2018-2025)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Gamma Medica Inc
9.5.1 Gamma Medica Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.5.3 Gamma Medica Inc Market Performance (2018-2025)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Siemens Healthcare
9.6.1 Siemens Healthcare Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.6.3 Siemens Healthcare Market Performance (2018-2025)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Nordion (Canada) Inc.
9.7.1 Nordion (Canada) Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.7.3 Nordion (Canada) Inc. Market Performance (2018-2025)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Curium
9.8.1 Curium Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.8.3 Curium Market Performance (2018-2025)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Hologic Inc.
9.9.1 Hologic Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.9.3 Hologic Inc. Market Performance (2018-2025)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 CMR Naviscan (Gamma Medica Inc.)
9.10.1 CMR Naviscan (Gamma Medica Inc.) Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.10.3 CMR Naviscan (Gamma Medica Inc.) Market Performance (2018-2025)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Cardinal Health Inc.
9.11.1 Cardinal Health Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.11.3 Cardinal Health Inc. Market Performance (2018-2025)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Agfa-Gevaert N.V.
9.12.1 Agfa-Gevaert N.V. Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.12.3 Agfa-Gevaert N.V. Market Performance (2018-2025)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Ge Healthcare
9.13.1 Ge Healthcare Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.13.3 Ge Healthcare Market Performance (2018-2025)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Digirad Corporation
9.14.1 Digirad Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.14.3 Digirad Corporation Market Performance (2018-2025)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Naviscan Inc
9.15.1 Naviscan Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.15.3 Naviscan Inc Market Performance (2018-2025)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Medx Inc
9.16.1 Medx Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.16.3 Medx Inc Market Performance (2018-2025)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Bracco S.p.A
9.17.1 Bracco S.p.A Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Nuclear Medicine Radioisotopes Product Profiles, Application and Specification
9.17.3 Bracco S.p.A Market Performance (2018-2025)
9.17.4 Recent Development
9.17.5 SWOT Analysis

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source